Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
From the Cyclooxygenase-2 Inhibitor Celecoxib to a Novel Class of 3-Phosphoinositide-Dependent Protein Kinase-1 Inhibitors
- J. Zhu, Jui-Wen Huang, +6 authors C. Chen
- Biology, Medicine
- Cancer Research
- 15 June 2004
The blockade of Akt activation through the inhibition of 3-phosphoinositide-dependent kinase-1 (PDK-1) represents a major signaling mechanism whereby celecoxib mediates apoptosis. Celecoxib, however,… Expand
3-Phosphoinositide-Dependent Protein Kinase-1/Akt Signaling Represents a Major Cyclooxygenase-2-Independent Target for Celecoxib in Prostate Cancer Cells
- S. Kulp, Ya-ting Yang, +6 authors C. Chen
- Medicine
- Cancer Research
- 15 February 2004
Regarding the involvement of cyclooxygenase-2 (COX-2)-independent pathways in celecoxib-mediated antineoplastic effects, the following two issues remain outstanding: identity of the non-COX-2 targets… Expand
Cell-intrinsic transforming growth factor-beta signaling mediates virus-specific CD8+ T cell deletion and viral persistence in vivo.
- Roberto Tinoco, Victor Alcalde, Ya-ting Yang, K. Sauer, E. Zúñiga
- Biology, Medicine
- Immunity
- 17 July 2009
Although deficient CD8(+) T cell responses have long been associated with chronic viral infections, the underlying mechanisms are still unclear. Here we report that sustained transforming growth… Expand
Knowledge and attitudes of medical staff in Chinese psychiatric hospitals regarding COVID-19
- Y. Shi, J. Wang, +5 authors Huanzhong Liu
- Medicine
- Brain, Behavior, & Immunity - Health
- 29 March 2020
Abstract
On March 11, 2020, the World Health Organization (WHO) declared the novel coronavirus COVID-19 a pandemic. There are patients in psychiatric hospitals in China who have been infected… Expand
Cyclooxygenase-2, player or spectator in cyclooxygenase-2 inhibitor-induced apoptosis in prostate cancer cells.
- X. Song, Ho-Pi Lin, +4 authors C. Chen
- Biology, Medicine
- Journal of the National Cancer Institute
- 17 April 2002
BACKGROUND
The antitumor activity of cyclooxygenase-2 (COX-2) inhibitors is thought to involve COX-2 enzyme inhibition and apoptosis induction, but it is unclear whether COX-2 inhibition is required… Expand
Peroxisome Proliferator-Activated Receptor γ-Independent Ablation of Cyclin D1 by Thiazolidinediones and Their Derivatives in Breast Cancer Cells
- Jui-Wen Huang, C. Shiau, +5 authors C. Chen
- Biology
- Molecular Pharmacology
- 1 April 2005
In light of the clinical relevance of targeting cyclin D1 in breast cancer, we have investigated the mechanism underlying the effect of the peroxisome proliferator-activated receptor-γ (PPARγ)… Expand
Peroxisome proliferator-activated receptor gamma-independent ablation of cyclin D1 by thiazolidinediones and their derivatives in breast cancer cells.
- Jui-Wen Huang, Chung-Wai Shiau, +5 authors C. Chen
- Medicine
- Molecular pharmacology
- 2005
In light of the clinical relevance of targeting cyclin D1 in breast cancer, we have investigated the mechanism underlying the effect of the peroxisome proliferator-activated receptor-gamma… Expand
Bcl-xL Mediates a Survival Mechanism Independent of the Phosphoinositide 3-Kinase/Akt Pathway in Prostate Cancer Cells*
Among various molecular strategies by which prostate cancer cells evade apoptosis, phosphoinositide 3-kinase (PI3K)/Akt signaling represents a dominant survival pathway. However, different prostate… Expand
Caveolar Endocytosis Is Required for Human PSGL-1-Mediated Enterovirus 71 Infection
- Hsiang-Yin Lin, Ya-ting Yang, +4 authors Y. Chow
- Biology, Medicine
- Journal of Virology
- 12 June 2013
ABSTRACT Enterovirus 71 (EV71) causes hand, foot, and mouth disease and severe neurological disorders in children. Human scavenger receptor class B member 2 (hSCARB2) and P-selectin glycoprotein… Expand
Peroxisome Proliferator-Activated Receptor-Independent Ablation of Cyclin D 1 by Thiazolidinediones and Their Derivatives in Breast Cancer Cells
- Jui-Wen Huang, Chung-Wai Shiau, +5 authors C. Chen
- 2005
In light of the clinical relevance of targeting cyclin D1 in breast cancer, we have investigated the mechanism underlying the effect of the peroxisome proliferator-activated receptor(PPAR ) agonists… Expand